Few studies to date have investigated SGLT2 inhibitors in patients with FD specifically; however, one small case-series of 11 patients demonstrated that SGLT2 inhibitors successfully reduced albuminuria [113]. The gene discussed is SLC5A2; the disease is Fabry disease.